乳腺癌非药物干预患者版指南

标题: 乳腺癌非药物干预患者版指南
title: Patient Version of Guideline for Non-Pharmacological Interventions in Breast Cancer
版本: 原创版
version: Original
分类: 患者版本指南
classification: Patient version of guideline
领域: 综合
field: Comprehensive guideline
国家和地区: 中国
Country and region: China
指南使用者: 指南的使用人群为乳腺癌患者、家属及其照顾者、与乳腺癌管理相关的卫生专业人员、医疗政策的制定者、教育工作者、新闻媒体工作者等公众群体。
Guide users: The intended users of the guideline include patients with BC, their family members and caregivers, health professionals, policymakers in the medical field, educators, journalists, and other public organizations related to breast cancer management.
证据分级方法: 本患者指南采用推荐分级的评价、制订与评估(the grading of recommendations assessment, development and evaluation, GRADE)对来自系统评价的证据进行质量分级。
Evidence grading method: The GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach will be used to grade the quality of the evidence derived from systematic reviews and make recommendations.
制定单位: 南方医院JBI循证护理合作中心
Formulating unit: Nanfang Nursing Centre of Evidence-based Practice: A JBI Centre of Excellence in Guangzhou, China
注册时间: 2024-04-23
Registration time:
注册编号: PREPARE-2024CN575
Registration number:
指南制订的目的: 为了进一步增进患者和公众对乳腺癌非药物干预相关知识的理解,促进医患沟通和共同决策,并提高公共健康素养,亟需制订一部以患者为中心的乳腺癌非药物干预指南。本患者指南旨在提供及时、可靠的乳腺癌非药物干预建议,以帮助乳腺癌患者掌握有关疾病知识,提高自我管理能力,预防不良结局的发生,并减轻患者因疾病带来的心理负担。
Purpose of the guideline: To further enhance understanding among patients and the public regarding non-pharmacological interventions for BC, foster enhanced doctor-patient communication and shared decision-making, and promote public health literacy, it is imperative to formulate a patient-centric guideline for non-pharmacological interventions in BC. This guideline aims to provide timely and reliable suggestions for non-pharmacologic interventions in breast cancer to help patients with BC acquire knowledge about the disease, improve self-management ability, prevent adverse outcomes, and alleviate the psychological burden of the disease.